Northwestern Mutual Investment Management Company’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $4.04M | Buy |
8,137
+10
| +0.1% | +$4.43K | 0.05% | 129 |
|
|
2026
Q1 | $3.63M | Buy |
8,127
+20
| +0.2% | +$9.33K | 0.06% | 126 |
|
|
2025
Q4 | $3.68M | Sell |
8,107
-64
| -0.8% | -$27.6K | 0.04% | 126 |
|
|
2025
Q3 | $3.2M | Sell |
8,171
-22
| -0.3% | -$9.19K | 0.05% | 150 |
|
|
2025
Q2 | $3.65M | Buy |
8,193
+26
| +0.3% | +$12K | 0.06% | 113 |
|
|
2025
Q1 | $3.96M | Sell |
8,167
-10
| -0.1% | -$4.66K | 0.06% | 90 |
|
|
2024
Q4 | $3.29M | Sell |
8,177
-4
| -0% | -$1.85K | 0.07% | 115 |
|
|
2024
Q3 | $3.8M | Sell |
8,181
-32
| -0.4% | -$15.4K | 0.09% | 92 |
|
|
2024
Q2 | $3.85M | Buy |
8,213
+35
| +0.4% | +$15.2K | 0.1% | 88 |
|
|
2024
Q1 | $3.42M | Buy |
8,178
+21
| +0.3% | +$8.88K | 0.09% | 104 |
|
|
2023
Q4 | $3.32M | Buy |
8,157
+11
| +0.1% | +$4.06K | 0.09% | 93 |
|
|
2023
Q3 | $2.83M | Buy |
8,146
+22
| +0.3% | +$7.69K | 0.08% | 99 |
|
|
2023
Q2 | $2.86M | Buy |
8,124
+43
| +0.5% | +$14.5K | 0.07% | 105 |
|
|
2023
Q1 | $2.55M | Buy |
8,081
+36
| +0.4% | +$10.8K | 0.07% | 113 |
|
|
2022
Q4 | $2.32M | Sell |
8,045
-1,481
| -16% | -$451K | 0.06% | 108 |
|
|
2022
Q3 | $2.76M | Sell |
9,526
-1,815
| -16% | -$522K | 0.07% | 94 |
|
|
2022
Q2 | $3.2M | Buy |
11,341
+78
| +0.7% | +$20.9K | 0.07% | 100 |
|
|
2022
Q1 | $2.94M | Sell |
11,263
-1,353
| -11% | -$321K | 0.07% | 133 |
|
|
2021
Q4 | $2.77M | Sell |
12,616
-382
| -3% | -$74.3K | 0.05% | 162 |
|
|
2021
Q3 | $2.36M | Buy |
12,998
+1,242
| +11% | +$242K | 0.05% | 168 |
|
|
2021
Q2 | $2.37M | Sell |
11,756
-29
| -0.2% | -$6.07K | 0.04% | 169 |
|
|
2021
Q1 | $2.53M | Sell |
11,785
-2,486
| -17% | -$546K | 0.04% | 150 |
|
|
2020
Q4 | $3.37M | Buy |
14,271
+27
| +0.2% | +$6.2K | 0.04% | 164 |
|
|
2020
Q3 | $4.13M | Hold |
14,244
| – | – | 0.06% | 108 |
|
|
2020
Q2 | $4.13M | Buy |
14,244
+844
| +6% | +$229K | 0.06% | 105 |
|
|
2020
Q1 | $3.19M | Buy |
13,400
+3,410
| +34% | +$782K | 0.05% | 114 |
|
|
2019
Q4 | $2.19M | Buy |
9,990
+202
| +2% | +$40.9K | 0.04% | 195 |
|
|
2019
Q3 | $1.66M | Buy |
9,788
+73
| +0.8% | +$12.9K | 0.04% | 269 |
|
|
2019
Q2 | $1.78M | Sell |
9,715
-29,134
| -75% | -$5.09M | 0.04% | 233 |
|
|
2019
Q1 | $7.15M | Buy |
38,849
+335
| +0.9% | +$61.9K | 0.13% | 141 |
|
|
2018
Q4 | $6.38M | Sell |
38,514
-6,207
| -14% | -$1.08M | 0.11% | 147 |
|
|
2018
Q3 | $8.62M | Sell |
44,721
-4,077
| -8% | -$726K | 0.13% | 142 |
|
|
2018
Q2 | $8.29M | Buy |
48,798
+2,583
| +6% | +$400K | 0.12% | 156 |
|
|
2018
Q1 | $7.53M | Sell |
46,215
-10,909
| -19% | -$1.78M | 0.13% | 150 |
|
|
2017
Q4 | $8.56M | Buy |
57,124
+599
| +1% | +$88.7K | 0.14% | 148 |
|
|
2017
Q3 | $8.59M | Sell |
56,525
-630
| -1% | -$94.8K | 0.14% | 141 |
|
|
2017
Q2 | $7.37M | Buy |
57,155
+6,935
| +14% | +$835K | 0.12% | 161 |
|
|
2017
Q1 | $5.49M | Buy |
50,220
+36,851
| +276% | +$3.24M | 0.1% | 185 |
|
|
2016
Q4 | $985K | Sell |
13,369
-11,145
| -45% | -$907K | 0.02% | 498 |
|
|
2016
Q3 | $2.14M | Buy |
24,514
+15,079
| +160% | +$1.43M | 0.05% | 235 |
|
|
2016
Q2 | $812K | Buy |
9,435
+28
| +0.3% | +$2.42K | 0.02% | 367 |
|
|
2016
Q1 | $748K | Buy |
9,407
+73
| +0.8% | +$6.6K | 0.02% | 388 |
|
|
2015
Q4 | $1.17M | Buy |
9,334
+322
| +4% | +$38.9K | 0.02% | 329 |
|
|
2015
Q3 | $939K | Buy |
9,012
+57
| +0.6% | +$7.32K | 0.02% | 382 |
|
|
2015
Q2 | $1.11M | Sell |
8,955
-25,997
| -74% | -$3.28M | 0.02% | 374 |
|
|
2015
Q1 | $4.12M | Buy |
+34,952
| New | +$4.19M | 0.08% | 157 |
|
Other funds holding VRTX
Northwestern Mutual Investment Management Company's VRTX Position: Q2 2026 in Review
Northwestern Mutual Investment Management Company increased its Vertex Pharmaceuticals (VRTX) stake by 0.12% in Q2 2026, buying an estimated $4.43K and bringing the position to 8,137 shares worth $4.04M. The position accounts for 0.05% of the portfolio, ranked #129.
Northwestern Mutual Investment Management Company first reported a position in VRTX in Q1 2015 and has held it in 46 quarters since. The position peaked at $8.62M in Q3 2018. 1,304 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- Northwestern Mutual Investment Management Company held 8,137 shares of Vertex Pharmaceuticals worth $4.04M as of Q2 2026.
- Northwestern Mutual Investment Management Company bought 10 Vertex Pharmaceuticals shares in Q2 2026, an estimated $4.43K.
- Vertex Pharmaceuticals made up 0.05% of Northwestern Mutual Investment Management Company's portfolio in Q2 2026, its #129 holding.
- Northwestern Mutual Investment Management Company first reported a position in Vertex Pharmaceuticals in Q1 2015 and has held it in 46 quarters since.
- Northwestern Mutual Investment Management Company's Vertex Pharmaceuticals position peaked at $8.62M in Q3 2018.
- 1,304 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on Northwestern Mutual Investment Management Company's 13F filing for Q2 2026, filed 12 Aug 2026.